SynthesisScientific reports2015

Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer.

Bo Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.